Factor D inhibitors (UCB)

N/A

Report date: 2025/03/20 16:05:21
NME

Base Information

Drug NameFactor D inhibitors (UCB)
Drug Alias NameFactor D inhibitors (Ra Pharmaceuticals)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionComplement factor D inhibitors
TargetsComplement factor D
Therapy Area/IndicationsGlomerulonephritis, MembranoproliferativeGlomerulonephritisGeographic Atrophy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRa Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesUcb Sa
Inactive CompaniesRa Pharmaceuticals Inc
Active IndicationsGlomerulonephritis, MembranoproliferativeGlomerulonephritisGeographic Atrophy
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A